ArticlePharmacoEconomics2023

Are We Capturing the Socioeconomic Burden of Rare Genetic Disease? A Scoping Review of Economic Evaluations and Cost-of-Illness Studies.

Deborah A Marshall et al.PubMed ↗Publisher ↗

No numbers read from the abstract.